|
|
|
|
Opposing functions of a key molecule in the development of organisms
The same molecule is also involved in cancer and studies of its activity may provide new clues for the design of effective therapies This release is available in Spanish.IMAGE:This is a Drosophila wing disc containing a group of cells (in green)...
|
|
|
Diclofenac Gel Clears Actinic Keratoses Among Organ Transplant Recipients: Presented at AAD
-- Organ transplant recipients who are at high risk for skin cancer are able to clear dangerous actinic keratoses if they were treated with 3% diclofenac in 2.5% hyaluronic acid gel rather than with placebo, researchers said here at the 68th Annual...
|
|
|
Genmab announces results from zalutumumab phase III study of refractory head & neck cancer patients
Genmab A/S announced top-line results from a zalutumumab phase III study in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) who failed standard platinum-based chemotherapy.Median overall survival in...
|
|
|
VAI Researchers Develop Tool to Help Study Prostate Cancer
Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer.Using the model, they found that normal cells and cancer...
|
|
|
Van Andel Researchers Zero In On Prostrate Cancer Treatment
GRAND RA S - Van Andel Research Institute researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer.Using the model, they found that normal cells and ...
|
|
|
New tool to help study prostate cancer developed
Van Andel Research Institute (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer.Using the model, they found that normal cells and cancer...
|
|
|
New method to better study prostate cancer
New model allows researchers to find differences in survival mechanisms for normal cells and cancer cells that could aid in developing treatments Van Andel Research Institute (VARI) researchers have developed a new method to better study the ...
|
|
|
Curis to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference
Cancer Breaking News News source: Business Wire Curis, Inc.(NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be...
|
|
|
ImmunoGen's Skin Cancer Treatment Wins Orphan Drug Status
The US Food and Drug Administration (FDA) has granted orphan drug designation to ImmunoGen's investigational skin cancer drug IMGN901.In an early-stage trial, the drug is being developed to treat Merkel cell carcinoma (MCC), which is...
|
|
|
Association of the DSS1 c.143G>A Polymorphism with Skin Squamous Cell Carcinoma
Association of the DSS1 c.143G>A Polymorphism with Skin Squamous Cell Carcinoma Journal of Investigative Dermatology advance online publication, March 11, 2010.doi:10.1038/jid.2010. Association of the DSS1 c.143G>A Polymorphism with...
Journal of Investigative Dermatology:
Mar 11 2010 11:05AM
Matching: cell carcinoma skin
|
Find similar documents
|
|
|
|
Tool Developed To Help Study Prostate Cancer
New model allows researchers to find differences in survival mechanisms for normal cells and cancer cells that could aid in developing treatments Van Andel Research Institute (VARI) researchers have developed a new method to better study the ...
|
|
|
VAI researchers develop tool to help study prostate cancer
- (VARI) researchers have developed a new method to better study the cells that line and protect the prostate in relation to the development of cancer.Using the model, they found that normal cells and cancer cells depend on...
|
|
|
BRIEF: Taro gets FDA approval for anti-cancer cream: The equivalent branded treatment had sales of $70 million in the US in 2009
Taro Pharmaceutical Industries Ltd.(Pink Sheets: TAROF) today reported that it received approval from the US Food and Drug Administration (FDA) for fluorouracil cream. Fluorouracil is bioequivalent to Efudex Topical Cream 5 percent manufactured by Valeant...
|
|
|
Curis to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference
CAMBRIDGE, Mass.-- (BUSINESS WIRE) -- Curis, Inc.(NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the 22nd...
|
|
|
Curis to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference
- Curis, Inc.(NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the ROTH Capital Partners 22nd Annual OC...
|
|
|
Curis to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Curis, Inc.(NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the Company will be presenting at the ROTH...
|
|
|
Curis to Present at the ROTH Capital Partners 22nd Annual OC Growth Stock Conference
Companies mentioned in this article: Curis, Inc.CAMBRIDGE, Mass. -- (BUSINESS WIRE) -- Curis, Inc. (NASDAQ: CRIS), a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today...
|
|
|
AAD: Signal Inhibitor Active in Basal Cell Carcinoma
Signal Inhibitor Active in Basal Cell Carcinoma - in , from MedPage Today NEW CME/CE TRACKER Personalize Your Medical News: CME Information Jointly Sponsored by: and MedPage Today.CREDITS Physicians: 0.25 AMA PRA Category 1 Credit(s) Family...
|
|
|
Taro Pharmaceutical wins FDA approval for fluorouracil cream
(Datamonitor via COMTEX) Taro Pharmaceutical Industries has received the FDA's approval of its abbreviated new drug application for fluorouracil topical cream USP, 5%, fluorouracil cream.According to Taro Pharmaceutical Industries, its fluorouracil cream is...
|
|
|
Taro Pharmaceutical wins FDA approval for fluorouracil cream
Taro Pharmaceutical Industries has received the FDA's approval of its abbreviated new drug application for fluorouracil topical cream USP, 5%, fluorouracil cream.According to Taro Pharmaceutical Industries, its fluorouracil cream is a prescription...
|
|
|
Taro Receives FDA Approval for Fluorouracil Topical Cream USP, 5%
Generic Equivalent to Valeants Efudex Topical Cream 5% HAWTHORNE, N.Y.-- (BUSINESS WIRE) -- Taro Pharmaceutical Industries Ltd.('Taro' or the 'Company,' Pink Sheets: TAROF) today reported that it received approval from the U.S. Food and Drug Administration...
|
|
|
Genmab Announces Results from Zalutumumab Phase III Study of Refractory Head and Neck Cancer Patients
- Genmab A/S announced top-line results from a zalutumumab Phase III study in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN) who failed standard platinum-based chemotherapy.Median overall survival in...
|
|
|
Genmab shares sink as cancer drug fails in Phase III study
Shares in Genmab have taken a bashing after the company said that a late-stage trial of zalutumumab in head and neck cancer failed to meet its main goal.The Danish company has announced top-line results from a zalutumumab Phase III study in patients...
|
|
|
Graceway Announces Journal Of The American Academy Of Dermatology Publishes Articles On New Short-Course Imiqu
Graceway Announces Journal Of The American Academy Of Publishes Articles On New Short-Course Imiquimod Formulation In Actinic Keratosis Journal of the American Academy of (JAAD) has published Phase III data evaluating the safety and efficacy of imiquimod cream...
|
|
|
Taro gets FDA approval for anti-cancer cream
The equivalent branded treatment had sales of $70 million in the US in 2009.Taro Pharmaceutical Industries Ltd.(Pink Sheets: TAROF) today reported that it received approval from the US Food and Drug Administration (FDA) for fluorouracil cream. Fluorouracil...
|
